Platelet Activating Factor/Platelet Activating Factor Receptor Pathway as a Potential Therapeutic Target in Autoimmune Diseases

Publisher： Bentham Science Publishers

E-ISSN： 2212-4055|8|3|182-190

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.8, Iss.3, 2009-07, pp. : 182-190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist

By Albert D.H. Magoc T.J. Tapang P. Luo G. Morgan D.W. Curtin M. Sheppard G.S. Xu L. Heyman H.R. Davidsen S.K. Summers J.B. Carter G.W.

European Journal of Pharmacology, Vol. 325, Iss. 1, 1997-04 ,pp. : 69-80

Elsevier

Access to resources Recommend Favorite

Ocular actions of platelet-activating factor: clinical implications

By Nitoda Eirini Moschos Marilita M Mavragani Clio P Koutsilieris Michael

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 10, 2012-10 ,pp. : 1027-1039

Informa Healthcare

Access to resources Recommend Favorite

Regional haemodynamic effects of platelet activating factor in the rat

By King K.A. Lim S.L. Pang C.C.Y.

European Journal of Pharmacology, Vol. 281, Iss. 2, 1995-08 ,pp. : 187-193

Elsevier

Access to resources Recommend Favorite

Current status of platelet-activating factor antagonists

By Curtin M.L.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 6, 1998-06 ,pp. : 703-711

Informa Healthcare

Access to resources Recommend Favorite

Triflavin potentiates the antiplatelet activity of platelet activating factor receptor antagonist on activated neutrophil-induced platelet aggregation

By Lee L.-W. Peng H.-C. Ko W.-C. Hung W.-C. Su C.-H. Lin C.-H. Huang T.-F. Yen M.-H. Sheu J.-R.

European Journal of Pharmacology, Vol. 364, Iss. 2, 1999-01 ,pp. : 239-246

Elsevier

Access to resources Recommend Favorite